Interferon beta-1b and tacrolimus (DrugBank: Interferon beta-1b, Tacrolimus, Interferon beta)
32 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
2 | Amyotrophic lateral sclerosis | 0 |
6 | Parkinson disease | 0 |
11 | Myasthenia | 0 |
13 | Multiple sclerosis/Neuromyelitis optica | 1 |
36 | Epidermolysis bullosa | 0 |
46 | Malignant rheumatoid arthritis | 0 |
49 | Systemic lupus erythematosus | 0 |
50 | Dermatomyositis | 0 |
51 | Scleroderma | 0 |
53 | Sjogren syndrome | 0 |
60 | Aplastic anemia | 0 |
61 | Autoimmune hemolytic anemia | 0 |
62 | Paroxysmal nocturnal hemoglobinuria | 0 |
65 | Primary immunodeficiency | 0 |
66 | IgA nephropathy | 0 |
85 | Idiopathic interstitial pneumonia | 0 |
95 | Autoimmune hepatitis | 0 |
96 | Crohn disease | 0 |
97 | Ulcerative colitis | 0 |
113 | Muscular dystrophy | 0 |
151 | Rasmussen encephalitis | 0 |
158 | Tuberous sclerosis | 0 |
164 | Oculocutaneous albinism | 0 |
222 | Primary nephrotic syndrome | 0 |
224 | Purpura nephritis | 0 |
226 | Interstitial cystitis with Hunners ulcer | 0 |
227 | Osler disease | 0 |
228 | Bronchiolitis obliterans | 0 |
283 | Acquired pure red cell aplasia | 0 |
284 | Diamond-Blackfan anemia | 0 |
285 | Fanconi anemia | 0 |
299 | Cystic fibrosis | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00298662 (ClinicalTrials.gov) | February 2003 | 2/3/2006 | Combination Therapy of Betaseron-Prograf in Multiple Sclerosis | A Pilot Safety and Tolerability Open-Label Study of Interferon Beta-1b in Combination With Tacrolimus in Patients Suffering From Multiple Sclerosis Who Have Failed Treatment With Approved Disease Modifying Agents | Multiple Sclerosis | Drug: Interferon beta-1b and Tacrolimus | Clinique de sclérose en plaques et neuromusculaire de l'Outaouais | NULL | Active, not recruiting | 18 Years | 55 Years | Both | 30 | Phase 2 | Canada |